A bio-tech company shaping the future of marine antifouling coatings

We are the developers of Selektope - an active antifouling agent that repels barnacles from ships.

This is I-Tech AB

I-Tech is a Nasdaq First North Growth Market-listed bio-technology company [TICKER:ITECH] based in  Sweden. We develop, market and sell the performance ingredient, Selektope® for use in marine antifouling coatings.

Our vision is to establish Selektope® as the leading technology to prohibit marine growth in an effective and sustainable way.

About I-Tech
CORPORATE CONTACTS
2138931381 (1)

Markus Jönsson

CEO

ma************@i-****.se

Magnus Henell, CFO

Magnus Henell

CFO & Head of Operations

ma***********@i-****.se

Monica Kettelhoit

Monica Kettelhoit

Office Manager

mo***************@i-****.se

Selektope logo light

Its powerful, repellent effect on barnacles keeps the ship's hull clean

Visit selektope.com

Selektope® - ECHA Consultation: Your Voice Matters

Your support is vital. Join the public consultation to protect our waterways and ensure a sustainable future.

You can submit comments to ECHA's public consultation to help ensure Selektope remains available for use in the EU.

Read more

The European Chemicals Agency (ECHA) is an agency of the EU working for the safe use of chemicals. Biocides are approved by stringent regulatory schemes across different geographies. In the EU, all biocides undergo an extensive approval process under the EU Biocidal Products Regulation.

ECHA is considering the renewal of Medetomidine, the crucial component of our antifouling product, Selektope. If not approved, Selektope's future in the EU market is at risk.

Latest news

Show all

2024

2024-10-18 08:00 I-Tech AB (publ) (ticker: ITECH) publish the interim report for the third quarter 2024 Regulatory MAR
I-Tech's CEO, Markus Jönsson and I-Tech´s CFO, Magnus Henell present the report live on 18th of October, at 10:30.Follow the broadcast...
2024-09-17 08:35 I-Tech AB Announces Public Consultation for Selektope Renewal in the EU
I-Tech AB, the innovative biotechnology company behind the antifouling agent Selektope, is announcing that the European Chemicals Agency (ECHA) has initiated...
2024-09-16 08:30 Markus Jönsson has formally taken office as CEO in I-Tech Regulatory
The Company announces that Markus Jönsson today has taken office as CEO after acting CEO, Magnus Henell. As communicated by the Company in a press...
Latest Presentation

ABG Sundal Collier Fireside Chat

March 11, 2024

I-Tech´s CFO, Magnus Henell in an interviw at ABG Sundal Collier

(18 minutes)

 

More presentations
Investor Communications

Sign up here to get the latest press releases and financial reports from I-Tech AB directly to your inbox.